Clinical trials show that nausea affects 12-22% of people taking Mounjaro, particularly when starting treatment or increasing doses
The medication may reduce the effectiveness of oral contraceptives, particularly after initiation and dose increases
Tirzepatide has demonstrated robust HbA1c reductions in clinical trials, with mean decreases ranging from 1.9% to 2.4% from baseline, depending on dose and baseline values
Studies show that people with obesity and IBD are at higher risk of developing additional health issues, lending weight to exploring this intersection (3)
Enter your vial size, water volume, and target dose
For a full breakdown, read our guide here